Biomarkers have transformed how breast cancer is diagnosed, classified, and managed. This post explores the diagnostic and prognostic significance of markers such as ER, PR, and HER2, and how their interpretation shapes personalized treatment decisions. Recent advances in immunohistochemistry and molecular testing have further refined diagnostic accuracy, improving outcomes for patients.
Understanding the Diagnostic Value of Biomarkers in Breast Cancer
